{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:08:13Z","timestamp":1777590493017,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,10,19]],"date-time":"2013-10-19T00:00:00Z","timestamp":1382140800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s00277-013-1915-x","type":"journal-article","created":{"date-parts":[[2013,10,18]],"date-time":"2013-10-18T11:44:18Z","timestamp":1382096658000},"page":"603-608","source":"Crossref","is-referenced-by-count":15,"title":["Clinical significance of SF3B1 mutations in Korean patients with myelodysplastic syndromes and myelodysplasia\/myeloproliferative neoplasms with ring sideroblasts"],"prefix":"10.1007","volume":"93","author":[{"given":"Ja Young","family":"Seo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki-O","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun-Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kihyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chul Won","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun Ho","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,19]]},"reference":[{"key":"1915_CR1","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1073\/pnas.89.9.4028","volume":"89","author":"PD Cotter","year":"1992","unstructured":"Cotter PD, Baumann M, Bishop DF (1992) Enzymatic defect in \u201cX-linked\u201d sideroblastic anemia: molecular evidence for erythroid delta-aminolevulinate synthase deficiency. Proc Natl Acad Sci U S A 89:4028\u20134032","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1915_CR2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/ng.359","volume":"41","author":"DL Guernsey","year":"2009","unstructured":"Guernsey DL, Jiang H, Campagna DR, Evans SC, Ferguson M, Kellogg MD, Lachance M, Matsuoka M, Nightingale M, Rideout A, Saint-Amant L, Schmidt PJ, Orr A, Bottomley SS, Fleming MD, Ludman M, Dyack S, Fernandez CV, Samuels ME (2009) Mutations in mitochondrial carrier family gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia. Nat Genet 41:651\u2013653. doi: 10.1038\/ng.359","journal-title":"Nat Genet"},{"key":"1915_CR3","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1172\/JCI40372","volume":"120","author":"H Ye","year":"2010","unstructured":"Ye H, Jeong SY, Ghosh MC, Kovtunovych G, Silvestri L, Ortillo D, Uchida N, Tisdale J, Camaschella C, Rouault TA (2010) Glutaredoxin 5 deficiency causes sideroblastic anemia by specifically impairing heme biosynthesis and depleting cytosolic iron in human erythroblasts. J Clin Invest 120:1749\u20131761. doi: 10.1172\/jci40372","journal-title":"J Clin Invest"},{"key":"1915_CR4","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/hmg\/8.5.743","volume":"8","author":"R Allikmets","year":"1999","unstructured":"Allikmets R, Raskind WH, Hutchinson A, Schueck ND, Dean M, Koeller DM (1999) Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA\/A). Hum Mol Genet 8:743\u2013749","journal-title":"Hum Mol Genet"},{"key":"1915_CR5","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1086\/421530","volume":"74","author":"Y Bykhovskaya","year":"2004","unstructured":"Bykhovskaya Y, Casas K, Mengesha E, Inbal A, Fischel-Ghodsian N (2004) Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am J Hum Genet 74:1303\u20131308. doi: 10.1086\/421530","journal-title":"Am J Hum Genet"},{"key":"1915_CR6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/08035250500323715","volume":"95","author":"CJ Ricketts","year":"2006","unstructured":"Ricketts CJ, Minton JA, Samuel J, Ariyawansa I, Wales JK, Lo IF, Barrett TG (2006) Thiamine-responsive megaloblastic anaemia syndrome: long-term follow-up and mutation analysis of seven families. Acta Paediatr 95:99\u2013104. doi: 10.1080\/08035250500323715","journal-title":"Acta Paediatr"},{"key":"1915_CR7","first-page":"88","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"R Brunning","year":"2008","unstructured":"Brunning R, Orazi A, Germing U, Le Beau M, Porwit A, Bauman I, Vardiman JW, Hellstrom-Lindberg E (2008) Myelodysplastic syndromes\/neoplasms, overview. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Variman JW (eds) WHO classification of tumours of haematopoietic and lymphoid tissues. International Agency for Research on Cancer, Lyon, France, pp 88\u201393"},{"key":"1915_CR8","doi-asserted-by":"crossref","first-page":"e1970","DOI":"10.1371\/journal.pone.0001970","volume":"3","author":"J Boultwood","year":"2008","unstructured":"Boultwood J, Pellagatti A, Nikpour M, Pushkaran B, Fidler C, Cattan H, Littlewood TJ, Malcovati L, Della Porta MG, Jadersten M, Killick S, Giagounidis A, Bowen D, Hellstrom-Lindberg E, Cazzola M, Wainscoat JS (2008) The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts. PLoS One 3:e1970. doi: 10.1371\/journal.pone.0001970","journal-title":"PLoS One"},{"key":"1915_CR9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1182\/blood-2005-12-4769","volume":"108","author":"A Pellagatti","year":"2006","unstructured":"Pellagatti A, Cazzola M, Giagounidis AA, Malcovati L, Porta MG, Killick S, Campbell LJ, Wang L, Langford CF, Fidler C, Oscier D, Aul C, Wainscoat JS, Boultwood J (2006) Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype. Blood 108:337\u2013345. doi: 10.1182\/blood-2005-12-4769","journal-title":"Blood"},{"key":"1915_CR10","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature10496","volume":"478","author":"K Yoshida","year":"2011","unstructured":"Yoshida K, Sanada M, Shiraishi Y, Nowak D, Nagata Y, Yamamoto R, Sato Y, Sato-Otsubo A, Kon A, Nagasaki M, Chalkidis G, Suzuki Y, Shiosaka M, Kawahata R, Yamaguchi T, Otsu M, Obara N, Sakata-Yanagimoto M, Ishiyama K, Mori H, Nolte F, Hofmann WK, Miyawaki S, Sugano S, Haferlach C, Koeffler HP, Shih LY, Haferlach T, Chiba S, Nakauchi H, Miyano S, Ogawa S (2011) Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 478:64\u201369. doi: 10.1038\/nature10496","journal-title":"Nature"},{"key":"1915_CR11","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1056\/NEJMoa1103283","volume":"365","author":"E Papaemmanuil","year":"2011","unstructured":"Papaemmanuil E, Cazzola M, Boultwood J, Malcovati L, Vyas P, Bowen D, Pellagatti A, Wainscoat JS, Hellstrom-Lindberg E, Gambacorti-Passerini C, Godfrey AL, Rapado I, Cvejic A, Rance R, McGee C, Ellis P, Mudie LJ, Stephens PJ, McLaren S, Massie CE, Tarpey PS, Varela I, Nik-Zainal S, Davies HR, Shlien A, Jones D, Raine K, Hinton J, Butler AP, Teague JW, Baxter EJ, Score J, Galli A, Della Porta MG, Travaglino E, Groves M, Tauro S, Munshi NC, Anderson KC, El-Naggar A, Fischer A, Mustonen V, Warren AJ, Cross NC, Green AR, Futreal PA, Stratton MR, Campbell PJ (2011) Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med 365:1384\u20131395. doi: 10.1056\/NEJMoa1103283","journal-title":"N Engl J Med"},{"key":"1915_CR12","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/leu.2011.232","volume":"26","author":"V Visconte","year":"2012","unstructured":"Visconte V, Makishima H, Jankowska A, Szpurka H, Traina F, Jerez A, O\u2019Keefe C, Rogers HJ, Sekeres MA, Maciejewski JP, Tiu RV (2012) SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts. Leukemia 26:542\u2013545. doi: 10.1038\/leu.2011.232","journal-title":"Leukemia"},{"key":"1915_CR13","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.1182\/blood-2011-09-377275","volume":"118","author":"L Malcovati","year":"2011","unstructured":"Malcovati L, Papaemmanuil E, Bowen DT, Boultwood J, Della Porta MG, Pascutto C, Travaglino E, Groves MJ, Godfrey AL, Ambaglio I, Galli A, Da Via MC, Conte S, Tauro S, Keenan N, Hyslop A, Hinton J, Mudie LJ, Wainscoat JS, Futreal PA, Stratton MR, Campbell PJ, Hellstrom-Lindberg E, Cazzola M (2011) Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic\/myeloproliferative neoplasms. Blood 118:6239\u20136246. doi: 10.1182\/blood-2011-09-377275","journal-title":"Blood"},{"key":"1915_CR14","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/leu.2011.321","volume":"26","author":"F Damm","year":"2012","unstructured":"Damm F, Thol F, Kosmider O, Kade S, Loffeld P, Dreyfus F, Stamatoullas-Bastard A, Tanguy-Schmidt A, Beyne-Rauzy O, de Botton S, Guerci-Bresler A, Gohring G, Schlegelberger B, Ganser A, Bernard OA, Fontenay M, Heuser M (2012) SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications. Leukemia 26:1137\u20131140. doi: 10.1038\/leu.2011.321","journal-title":"Leukemia"},{"key":"1915_CR15","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.3324\/haematol.2012.072538","volume":"98","author":"S Jeromin","year":"2013","unstructured":"Jeromin S, Haferlach T, Grossmann V, Alpermann T, Kowarsch A, Haferlach C, Kern W, Schnittger S (2013) High frequencies of SF3B1 and JAK2 mutations in refractory anemia with ring sideroblasts associated with marked thrombocytosis strengthen the assignment to the category of myelodysplastic\/myeloproliferative neoplasms. Haematologica 98:e15\u2013e17. doi: 10.3324\/haematol.2012.072538","journal-title":"Haematologica"},{"key":"1915_CR16","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1038\/leu.2012.130","volume":"26","author":"V Visconte","year":"2012","unstructured":"Visconte V, Makishima H, Maciejewski JP, Tiu RV (2012) Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disorders. Leukemia 26:2447\u20132454. doi: 10.1038\/leu.2012.130","journal-title":"Leukemia"},{"key":"1915_CR17","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.leukres.2012.08.015","volume":"36","author":"R Cui","year":"2012","unstructured":"Cui R, Gale RP, Xu Z, Qin T, Fang L, Zhang H, Pan L, Zhang Y, Xiao Z (2012) Clinical importance of SF3B1 mutations in Chinese with myelodysplastic syndromes with ring sideroblasts. Leuk Res 36:1428\u20131433. doi: 10.1016\/j.leukres.2012.08.015","journal-title":"Leuk Res"},{"key":"1915_CR18","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1182\/blood-2011-09-377994","volume":"119","author":"MM Patnaik","year":"2012","unstructured":"Patnaik MM, Lasho TL, Hodnefield JM, Knudson RA, Ketterling RP, Garcia-Manero G, Steensma DP, Pardanani A, Hanson CA, Tefferi A (2012) SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value. Blood 119:569\u2013572. doi: 10.1182\/blood-2011-09-377994","journal-title":"Blood"},{"key":"1915_CR19","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1182\/blood-2012-03-415356","volume":"119","author":"MM Patnaik","year":"2012","unstructured":"Patnaik MM, Hanson CA, Sulai NH, Hodnefield JM, Knudson RA, Ketterling RP, Lasho TL, Tefferi A (2012) Prognostic irrelevance of ring sideroblast percentage in World Health Organization-defined myelodysplastic syndromes without excess blasts. Blood 119:5674\u20135677. doi: 10.1182\/blood-2012-03-415356","journal-title":"Blood"},{"key":"1915_CR20","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1182\/blood-2011-12-399337","volume":"119","author":"F Thol","year":"2012","unstructured":"Thol F, Kade S, Schlarmann C, Loffeld P, Morgan M, Krauter J, Wlodarski MW, Kolking B, Wichmann M, Gorlich K, Gohring G, Bug G, Ottmann O, Niemeyer CM, Hofmann WK, Schlegelberger B, Ganser A, Heuser M (2012) Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes. Blood 119:3578\u20133584. doi: 10.1182\/blood-2011-12-399337","journal-title":"Blood"},{"key":"1915_CR21","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1200\/JCO.2011.40.7379","volume":"30","author":"R Bejar","year":"2012","unstructured":"Bejar R, Stevenson KE, Caughey BA, Abdel-Wahab O, Steensma DP, Galili N, Raza A, Kantarjian H, Levine RL, Neuberg D, Garcia-Manero G, Ebert BL (2012) Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes. J Clin Oncol 30:3376\u20133382. doi: 10.1200\/jco.2011.40.7379","journal-title":"J Clin Oncol"},{"key":"1915_CR22","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.3324\/haematol.13405","volume":"93","author":"GJ Mufti","year":"2008","unstructured":"Mufti GJ, Bennett JM, Goasguen J, Bain BJ, Baumann I, Brunning R, Cazzola M, Fenaux P, Germing U, Hellstrom-Lindberg E, Jinnai I, Manabe A, Matsuda A, Niemeyer CM, Sanz G, Tomonaga M, Vallespi T, Yoshimi A (2008) Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts. Haematologica 93:1712\u20131717. doi: 10.3324\/haematol.13405","journal-title":"Haematologica"},{"key":"1915_CR23","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1182\/blood-2011-12-400994","volume":"119","author":"F Damm","year":"2012","unstructured":"Damm F, Kosmider O, Gelsi-Boyer V, Renneville A, Carbuccia N, Hidalgo-Curtis C, Della Valle V, Couronne L, Scourzic L, Chesnais V, Guerci-Bresler A, Slama B, Beyne-Rauzy O, Schmidt-Tanguy A, Stamatoullas-Bastard A, Dreyfus F, Prebet T, de Botton S, Vey N, Morgan MA, Cross NC, Preudhomme C, Birnbaum D, Bernard OA, Fontenay M (2012) Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes. Blood 119:3211\u20133218. doi: 10.1182\/blood-2011-12-400994","journal-title":"Blood"},{"key":"1915_CR24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/ng.1045","volume":"44","author":"CN Hahn","year":"2012","unstructured":"Hahn CN, Scott HS (2012) Spliceosome mutations in hematopoietic malignancies. Nat Genet 44:9\u201310. doi: 10.1038\/ng.1045","journal-title":"Nat Genet"},{"key":"1915_CR25","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1182\/blood-2011-12-399774","volume":"119","author":"H Makishima","year":"2012","unstructured":"Makishima H, Visconte V, Sakaguchi H, Jankowska AM, Abu Kar S, Jerez A, Przychodzen B, Bupathi M, Guinta K, Afable MG, Sekeres MA, Padgett RA, Tiu RV, Maciejewski JP (2012) Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis. Blood 119:3203\u20133210. doi: 10.1182\/blood-2011-12-399774","journal-title":"Blood"},{"key":"1915_CR26","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.leukres.2012.07.019","volume":"36","author":"K Matsuda","year":"2012","unstructured":"Matsuda K, Ishida F, Ito T, Nakazawa H, Miura S, Taira C, Sueki A, Kobayashi Y, Honda T (2012) Spliceosome-related gene mutations in myelodysplastic syndrome can be used as stable markers for monitoring minimal residual disease during follow-up. Leuk Res 36:1393\u20131397. doi: 10.1016\/j.leukres.2012.07.019","journal-title":"Leuk Res"},{"key":"1915_CR27","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1182\/blood-2012-05-430876","volume":"120","author":"V Visconte","year":"2012","unstructured":"Visconte V, Rogers HJ, Singh J, Barnard J, Bupathi M, Traina F, McMahon J, Makishima H, Szpurka H, Jankowska A, Jerez A, Sekeres MA, Saunthararajah Y, Advani AS, Copelan E, Koseki H, Isono K, Padgett RA, Osman S, Koide K, O\u2019Keefe C, Maciejewski JP, Tiu RV (2012) SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes. Blood 120:3173\u20133186. doi: 10.1182\/blood-2012-05-430876","journal-title":"Blood"},{"key":"1915_CR28","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1182\/blood-2012-09-399725","volume":"121","author":"M Cazzola","year":"2013","unstructured":"Cazzola M, Rossi M, Malcovati L (2013) Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms. Blood 121:260\u2013269. doi: 10.1182\/blood-2012-09-399725","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-013-1915-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-013-1915-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-013-1915-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T09:49:46Z","timestamp":1559036986000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-013-1915-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,19]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["1915"],"URL":"https:\/\/doi.org\/10.1007\/s00277-013-1915-x","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,19]]}}}